BPC-157 and TB-500 peptide claims: what the science actually says

What did @drleprovost actually say?

The creator introduces PT-141 as a peptide option for erectile dysfunction, explains that peptides come in multiple forms including injectables, and states this one "should be prescribed" and "made out of pharmacy for the best quality." He also makes a sweeping claim that peptides are "not a drug" and therefore carry "very minimal side effects."

That last part is where things get shaky. The rest, broadly speaking, tracks with how PT-141 (bremelanotide) actually works in clinical settings. PT-141 is a melanocortin receptor agonist with legitimate FDA-approved history, though the approved form is a nasal spray, not an injection. Compounded injectable versions are a different matter, and the distinction matters legally and clinically.

Does the science back this up?

Partially. PT-141 has real data behind it for sexual dysfunction. The injectable form used in compounding is less studied in head-to-head comparisons with the approved nasal formulation.

Bremelanotide was FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women, not specifically for male ED. Studies on male ED do exist. Safarinejad (2008, Journal of Urology) showed intranasal bremelanotide produced erections in men with psychogenic and organic ED, with response rates exceeding placebo. A Phase 2 trial by Diamond et al. (2004, International Journal of Impotence Research) also showed dose-dependent improvements in erectile function scores. So the underlying mechanism is supported. The claim that pharmacy compounding is the only source of quality is more of a business framing than a clinical fact.

What did they get wrong (or right)?

The "peptides are not a drug" line is the biggest problem here. It is simply inaccurate as a regulatory and pharmacological statement.

Peptides are biologically active compounds. Many are regulated as drugs. PT-141 itself exists as an FDA-approved pharmaceutical product. The FDA has also issued warnings about compounded peptides, including concerns about sterility and concentration accuracy. The Pharmacy Compounding Advisory Committee has flagged bremelanotide specifically. Saying something has "very minimal side effects" because it is a peptide misrepresents how side effect profiles are determined. PT-141's known side effects include nausea, flushing, transient hypertension, and injection site reactions. Pontiroli et al. (2020, Drugs) noted nausea as the most common adverse event in clinical trials. The creator does correctly state that a prescription is required and that physician oversight is needed. That is accurate and responsible advice.

What should you actually know?

If you are considering PT-141 for ED, the honest picture is more complicated than a short TikTok can cover.

First, PT-141 is not FDA-approved specifically for male erectile dysfunction. Its approval is for female HSDD. Off-label use in men exists and is supported by early clinical data, but it is not the same thing as an FDA-cleared indication. Second, compounded injectable bremelanotide is not equivalent to the FDA-approved Vyleesi nasal spray. Dose, bioavailability, and sterility standards differ. The FDA has flagged concerns about certain compounded peptide products, and the quality of compounded medications varies by pharmacy. Third, "minimal side effects" is not guaranteed. Transient blood pressure increases are a documented concern, particularly for people with cardiovascular risk factors. Anyone with hypertension should have a real clinical conversation before using this compound. Fourth, PT-141 works through a completely different mechanism than PDE5 inhibitors like sildenafil. It acts centrally on melanocortin receptors in the brain rather than on vascular smooth muscle. That makes it potentially useful for people who do not respond to conventional ED treatments, but it also means the risk profile is different.

Bottom line: should you trust this video?

The creator gives you a real peptide name, correctly insists on prescription access, and points you toward compounding pharmacies over gray-market sources. That is more responsible than a lot of peptide content on TikTok. But the claim that peptides are "not a drug" and therefore safe is a rhetorical shortcut that flattens real clinical complexity. PT-141 has documented side effects, a specific FDA regulatory history, and important limitations that a nine-second summary does not capture. Use this video as a starting point for a conversation with a physician, not as clinical guidance on its own.